MOPP regimen as primary chemotherapy for brain tumors in infants |
| |
Authors: | Jan van Eys Ayten Cangir Deborah Coody Beth Smith |
| |
Affiliation: | (1) Division of Pediatrics, UT MD Anderson Hospital and Tumor Institute, USA;(2) Department of Pediatrics, The University of Texas Medical School at Houston, USA |
| |
Abstract: | Summary Seventeen infants with central nervous system malignancies, all with tissue diagnosis, were treated with the combination chemotherapy nitrogen mustard, vincristine, procarbazine and a steroid (MOPP) as primary therapy following surgery. Diagnoses include: 7 astrocytomas (grade: 3-I, 3-II, 1-III), 6 medulloblastomas, 2 ependymoma/astrocytoma mixed, 1 ependymoma and 1 primitive neuroectodermal tumor. Fourteen were under 2 years of age, 2 between 2 and 3 years of age, and 1 between 3 and 4 years of age. Fifteen responded and 2 failed. Of the responders, 6 are in continuous complete remission (median duration 28.9+ months) and 9 are in relapse (median duration of remission 10.3 months). Of the 2 patients who failed and 9 who relapsed, 4 expired and 6 are living in partial or complete remission. We conclude that MOPP therapy is well tolerated, has effectiveness, and allows postponement of potentially debilitating radiotherapy in infants with brain tumors.Address for offprints: Jan van Eys, PhD MD, Department of Pediatrics, Box 87, UT MD Anderson Hospital, 6723 Bertner Avenue, Houston, Texas 77030. |
| |
Keywords: | brain tumors chemotherapy infants |
本文献已被 SpringerLink 等数据库收录! |
|